Patent · US Expired

Pyrrolopyrimidines and processes for the preparation thereof

US6140332A · kind A · utility

24Cited by

3References

25Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Peter Traxler · Allschwil, CH
Guido Bold · Gipf-Oberfrick, CH
Wolfgang Brill · Schopfheim, DE
Jorg Frei · Hölstein, CH

Key dates

Filing date	Jan 26, 1998
Grant date	Oct 31, 2000
Priority date	—
Expiry date	Jan 26, 2018

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Described are 7H-pyrrolo[2,3-d]pyrimidine derivatives of formula I ##STR1## wherein the symbols are as defined in claim 1. Those compounds inhibit tyrosine protein kinase and can be used in the treatment of hyperproliferative diseases, for example tumour diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.